Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Rheumatology · ANCA-Associated Vasculitis

Symptoms, Lab Results, and the Road to Diagnosis

At a Glance

ANCA-associated vasculitis (AAV) is diagnosed through a combination of physical symptoms, blood tests for PR3 and MPO antibodies, imaging, and tissue biopsies. Early signs often involve the sinuses, lungs, or kidneys. A tissue biopsy is considered the gold standard for confirming an AAV diagnosis.

Diagnosing AAV is often described as putting together a complex puzzle. Because the disease can affect almost any part of the body, doctors look for a combination of physical symptoms, laboratory markers, and imaging findings to confirm the diagnosis and determine which subtype you have [1][2].

Symptoms Across the Body

AAV symptoms vary depending on which organ systems are involved. While some symptoms are obvious, others can be subtle or easily mistaken for more common illnesses.

  • Ear, Nose, & Throat (ENT): Often the first area affected in GPA. Symptoms include chronic sinus pain, “crusting” or bleeding in the nose, ear infections, or even changes in the shape of the nose [1][3].
  • Lungs: May involve a persistent cough, shortness of breath, or coughing up blood. Imaging might show nodules (small lumps) or signs of bleeding (hemorrhage) [4][5].
  • Kidneys: This is often a “silent” symptom. You may not feel anything, but tests may show blood or protein in your urine, or a rise in creatinine (a waste product that reflects kidney health) [6][7].
  • Nerves & Skin: You may experience numbness, tingling (“pins and needles”), or weakness in your limbs, particularly in EGPA [8][9]. Skin involvement often looks like small purple or red spots (purpura) or ulcers [10].
  • Eyes: Redness, pain, or blurred vision (scleritis) can occur, especially in GPA [11].

Decoding Your Lab & Pathology Reports

When you look at your medical records, a few key terms will help you understand your status:

  • ANCA Specificity: Your report will list PR3-ANCA or MPO-ANCA. PR3 is most common in GPA, while MPO is common in MPA and EGPA. This helps your doctor classify the disease and plan your treatment [12][13].
  • Inflammatory Markers: Tests like CRP (C-Reactive Protein) and ESR (Sedimentation Rate) measure the general level of “fire” or inflammation in your body [1].
  • Biopsy Findings: A biopsy is the “gold standard” for diagnosis [6]. You might see:
    • Pauci-immune: Means the damage is caused by neutrophils, not a buildup of other immune proteins [13].
    • Crescents: Refers to a specific shape of scarring in the kidney filters, indicating active inflammation [7].
    • Granulomas: Clusters of inflammatory cells typical of GPA [14].

The 2022 ACR/EULAR Classification Criteria

In 2022, international experts updated the “scoring system” used to classify AAV subtypes. This system assigns points for various findings. For example:

  • GPA points: Awarded for things like nasal crusting, specific lung nodules on CT, and PR3-ANCA positivity [15].
  • MPA points: Awarded for kidney damage and MPO-ANCA positivity, while points are subtracted if GPA-specific symptoms are present [16].
  • EGPA points: Awarded for asthma, high eosinophil counts, and nerve damage [15].

Completeness Checklist

To ensure your care team has the full picture, a complete diagnostic workup should generally include:

  1. Bloodwork: ANCA (PR3/MPO), Creatinine, CRP/ESR, and a Complete Blood Count (CBC) to check eosinophils [1][2].
  2. Urinalysis: A “dipstick” or microscopic check for blood and protein [17].
  3. Imaging: A chest X-ray or, more accurately, a High-Resolution CT (HRCT) of the lungs [5].
  4. Tissue Biopsy: Often of the kidney, skin, or lung to confirm the diagnosis [6].
  5. Specialist Exams: Depending on your symptoms, this may include an ENT exam or an eye exam [1].

Back to Home

Common questions in this guide

What does PR3-ANCA or MPO-ANCA mean on my blood test?
These are specific antibodies found in ANCA-associated vasculitis. PR3 is most commonly associated with Granulomatosis with Polyangiitis (GPA), while MPO is typically seen in Microscopic Polyangiitis (MPA) and Eosinophilic Granulomatosis with Polyangiitis (EGPA). Knowing your specific antibody helps classify your disease and guide treatment.
Why do I need a biopsy if my blood tests show AAV?
A tissue biopsy, often from the kidney, lung, or skin, is considered the gold standard for diagnosing AAV. It confirms the disease by showing specific signs of inflammation, such as pauci-immune damage or granulomas, which helps your doctor make a definitive diagnosis.
What are the first signs of ANCA-associated vasculitis?
Early symptoms vary by the organs involved but often include ear, nose, and throat issues like chronic sinus pain or nasal crusting. Other early warning signs can include a persistent cough, new skin rashes, or numbness and tingling in your hands or feet.
What is 'pauci-immune' inflammation on a kidney biopsy?
Pauci-immune means the blood vessel damage in your tissue was caused mainly by white blood cells called neutrophils, rather than a buildup of other immune system proteins. This is a hallmark finding in ANCA-associated vasculitis and helps distinguish it from other types of autoimmune kidney disease.
How is my subtype of AAV determined?
Doctors use the 2022 ACR/EULAR classification criteria, which acts like a scoring system. Points are awarded based on your specific symptoms, lab results like ANCA specificity, and biopsy findings to determine if you have GPA, MPA, or EGPA.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Anti-neutrophil cytoplasmic antibody-associated vasculitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific organs are currently showing signs of AAV involvement according to my tests?
  2. 2.Does my biopsy show 'pauci-immune' inflammation or 'crescentic' lesions in the kidneys?
  3. 3.What was my 'score' on the 2022 ACR/EULAR criteria for my specific subtype?
  4. 4.How do my current creatinine and urinalysis results compare to the normal range?
  5. 5.Was an HRCT of my chest performed, and did it show any nodules or signs of bleeding?

References

References (17)
  1. 1

    2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

    Chung SA, Langford CA, Maz M, et al.

    Arthritis care & research 2021; (73(8)):1088-1105 doi:10.1002/acr.24634.

    PMID: 34235880
  2. 2

    Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV.

    Sanchez-Alamo B, Schirmer JH, Hellmich B, et al.

    RMD open 2023; (9(2)) doi:10.1136/rmdopen-2023-003083.

    PMID: 37349121
  3. 3

    First presentation of idiopathic granulomatosis with polyangiitis in an adolescent.

    Ashworth G, Sanmani S

    BMJ case reports 2026; (19(2)) doi:10.1136/bcr-2025-266449.

    PMID: 41644197
  4. 4

    Clinical Characteristics and Outcomes of Patients With ANCA-Associated Vasculitides in a Colombian Hospital.

    Santacruz-Sandoval E, López-Bonilla J, Guevara-Calderón LA, et al.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2022; (28(2)):e491-e497 doi:10.1097/RHU.0000000000001775.

    PMID: 35192595
  5. 5

    Uncommon Presentation of Granulomatosis with Polyangiitis Mimicking Metastatic Lung Cancer.

    Urbanska EM, Elversang J, Colville-Ebeling B, et al.

    Clinics and practice 2021; (11(2)):293-302 doi:10.3390/clinpract11020042.

    PMID: 34068864
  6. 6

    Factors associated with pauci-immune glomerulonephritis in patients undergoing kidney biopsy with positive anti-neutrophil cytoplasmic antibody results.

    Lee YJ, Lee J, Ahn SM, et al.

    Journal of nephrology 2025; (38(9)):2919-2928 doi:10.1007/s40620-025-02430-2.

    PMID: 41091444
  7. 7

    Clinical associations of renal involvement in ANCA-associated vasculitis.

    Kronbichler A, Shin JI, Lee KH, et al.

    Autoimmunity reviews 2020; (19(4)):102495 doi:10.1016/j.autrev.2020.102495.

    PMID: 32068190
  8. 8

    Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA.

    Nishi R, Koike H, Ohyama K, et al.

    Neurology 2020; (94(16)):e1726-e1737 doi:10.1212/WNL.0000000000009309.

    PMID: 32217776
  9. 9

    Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know.

    Zheng Y, Zhang Y, Cai M, et al.

    Frontiers in neurology 2018; (9()):1166 doi:10.3389/fneur.2018.01166.

    PMID: 30687221
  10. 10

    Granulomatosis with polyangiitis mimicking multisystem pyoderma gangrenosum: A case report.

    Gormley A, Green P

    SAGE open medical case reports 2024; (12()):2050313X241304229 doi:10.1177/2050313X241304229.

    PMID: 39665031
  11. 11

    Ocular manifestations of ANCA-associated vasculitis.

    Junek ML, Zhao L, Garner S, et al.

    Rheumatology (Oxford, England) 2023; (62(7)):2517-2524 doi:10.1093/rheumatology/keac663.

    PMID: 36440847
  12. 12

    Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis.

    Walker BS, Peterson LK, Koening C, et al.

    Autoimmunity reviews 2022; (21(6)):103100 doi:10.1016/j.autrev.2022.103100.

    PMID: 35452854
  13. 13

    The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA).

    Weiner M, Segelmark M

    Autoimmunity reviews 2016; (15(10)):978-82.

    PMID: 27481040
  14. 14

    A Rare Coexistence of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis and IgG4-Related Disease: A Case Report and Literature Review.

    Al-Saedi ZS, Alatta L, Miqdad MA, et al.

    Cureus 2025; (17(8)):e89738 doi:10.7759/cureus.89738.

    PMID: 40932947
  15. 15

    2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis.

    Grayson PC, Ponte C, Suppiah R, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2022; (74(3)):386-392 doi:10.1002/art.41982.

    PMID: 35106968
  16. 16

    2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis.

    Robson JC, Grayson PC, Ponte C, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2022; (74(3)):393-399 doi:10.1002/art.41986.

    PMID: 35106964
  17. 17

    Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome.

    Wester Trejo MAC, Floßmann O, Westman KW, et al.

    Rheumatology (Oxford, England) 2019; (58(1)):103-109 doi:10.1093/rheumatology/key260.

    PMID: 30551161

This page explains AAV symptoms and diagnostic tests for educational purposes. Always consult your rheumatologist or care team to interpret your specific lab results and imaging.